Skip to main content
Centene Corp. (CNC)
Insurance • Financial
Stock AI
News & Reports
July 28, 2026 Centene Corp. Reports Strong Q2 2026 Performance Amid Regulatory Challenges Centene Corp. reported a 10% revenue increase to $53.6 billion in Q2 2026, despite a decline in managed care membership. The company continues to expand its Medicaid and Medicare services while maintaining effective cost management strategies.
July 28, 2026 Centene Corporation Reports Strong Q2 2026 Results, Revises Full-Year Outlook Upward Centene Corporation's Q2 2026 results highlight a 10% revenue increase to $53.6 billion and improved earnings per share. The company has raised its full-year guidance, reflecting a strong recovery and focus on profitability amid a changing healthcare landscape.
July 28, 2026 Centene Corporation Announces Board of Directors Changes Centene Corporation has announced the retirement of Kenneth A. Burdick from its Board of Directors and the appointment of Paul J. Diaz, effective July 28, 2026. This leadership change reflects Centene's commitment to improving healthcare and its proactive governance approach in a changing industry.
July 10, 2026 Centene Corporation Set to Release Second Quarter Financial Results Centene Corporation is set to release its Q2 2026 financial results on July 28, 2026, at 6:00 a.m. ET, followed by a conference call at 8:30 a.m. ET. Investors can join via phone or online. A replay of the call will be available afterward.
July 09, 2026 Centene’s Meridian Health Plan Secures Key Medicaid Contract in Illinois Centene Corporation's Meridian Health Plan has been awarded a four-year Medicaid contract in Illinois, continuing its essential role in providing managed care services. With a focus on a whole-person approach, Meridian aims to improve healthcare access and outcomes for approximately 2.4 million residents.
June 22, 2026 Centene Corporation Welcomes Lauren M. Tyler to its Board of Directors Centene Corporation has appointed Lauren M. Tyler to its Board of Directors, effective June 19, 2026. With over 30 years of experience, Tyler brings a wealth of knowledge in investment banking and corporate governance, poised to strengthen Centene's mission in the evolving healthcare landscape.
April 28, 2026 Centene Corporation Reports Strong Q1 2026 Results: Key Metrics and Community Engagement Highlights Centene Corporation's Q1 2026 results reveal robust revenue growth of $49.94 billion, driven by premium yield and membership expansion. The company emphasizes community engagement through various initiatives, enhancing its commitment to social responsibility.
April 28, 2026 Centene Corp. Reports Strong Q1 2026 Results Amid Regulatory Challenges Centene Corporation's Q1 2026 results show a 7% revenue increase to $49.9 billion, despite a decrease in membership due to regulatory changes. The company remains focused on strategic growth in Medicaid and Medicare, maintaining strong financial health and operational efficiency.
April 10, 2026 Centene Corporation Set to Announce First Quarter Financial Results for 2026 Centene Corporation is set to release its Q1 2026 financial results on April 28, followed by an earnings call at 8:30 a.m. ET. Investors can participate via phone or webcast, with a replay available for 12 months.
April 06, 2026 Centene Corporation Unveils New Executive Leadership Structure Centene Corporation has announced a new executive leadership structure to improve operational efficiency and market responsiveness. Daniel Finke and Michael Carson have been appointed as Group Presidents, bringing extensive experience to drive strategic growth across the company's healthcare offerings.
March 18, 2026 Centene Corp. Launches Innovative "Food Is Medicine" Program to Combat Diabetes in Eastern Kentucky Centene Corp. has introduced a $550,000 'Food Is Medicine Program' to address diabetes in Eastern Kentucky, offering medically tailored meals and educational resources to Medicaid enrollees. This initiative aims to improve health outcomes by tackling food insecurity and chronic disease management in rural communities.
February 17, 2026 Centene Corp. Reports Significant Growth and Challenges in 2025 Annual Report Centene Corp.'s 2025 annual report highlights a remarkable revenue growth of 19% to $194.8 billion, despite challenges like membership decline and rising medical costs. The company remains focused on serving underserved populations while navigating a complex regulatory landscape.
February 09, 2026 Absolute Total Care Wins Prestigious Press Ganey Human Experience Pinnacle of Excellence Award Absolute Total Care has been awarded the 2025 Press Ganey Pinnacle of Excellence Award, recognizing its dedication to member-centered care. This achievement highlights their innovative communication strategies and commitment to enhancing the healthcare experience for their members.
February 06, 2026 Centene Corporation Reports 2025 Results and Announces 2026 Guidance Centene Corporation reported a strong financial performance for 2025, with significant revenue growth and strategic adjustments aimed at restoring profitability. The company provided optimistic guidance for 2026, forecasting improved earnings and continued focus on core operations and community welfare.
January 13, 2026 Centene Corporation Prepares for Fourth Quarter and Year-End Financial Results Centene Corporation has announced its fourth quarter and year-end earnings call scheduled for February 6, 2026. Investors can participate via phone or an online webcast to gain insights into the company's financial performance and future strategies.
October 29, 2025 Centene Corporation Reports Third Quarter 2025 Results: A Comprehensive Analysis Centene Corporation's Q3 2025 results indicate a rise in revenues to $49.69 billion, despite a significant $6.7 billion goodwill impairment. Growth in Medicare and Commercial sectors highlights potential recovery strategies, while challenges in managing costs persist.
October 29, 2025 Centene Corp. Reports Q3 2025 Results: A Complex Landscape Ahead Centene Corp. has reported a strong revenue growth of 18% in Q3 2025, reaching $49.7 billion, despite facing significant challenges including a $6.7 billion goodwill impairment and a decrease in Medicaid membership. The company is navigating a complex regulatory landscape while adjusting its strategies in response to changing healthcare demands.
October 15, 2025 Centene Corp. Press Release: Wellcare Enhances Medicare Offerings for 2026 Centene Corp. announced the expansion of Wellcare's Medicare Advantage and Prescription Drug Plans for 2026, targeting over 51 million beneficiaries. With a focus on dual-eligible individuals and enhanced member experiences, Wellcare aims to provide affordable, quality healthcare solutions across 32 states.
September 29, 2025 Centene Corporation to Release Third Quarter Financial Results on October 29, 2025 Centene Corporation will announce its third quarter financial results on October 29, 2025, with an earnings call scheduled for 9 AM ET. Investors can join via phone or listen online to gain insights into the company's performance.
September 24, 2025 Centene Corp. Celebrates Recognition on Forbes' Inaugural Best Employers for Company Culture List Centene Corporation has been recognized by Forbes as one of America's Best Employers for Company Culture for 2025, ranking among the top in the U.S. insurance sector. CEO Sarah M. London highlights the significance of a shared values-driven culture in enhancing performance and employee engagement.
August 20, 2025 Centene Corporation Advises Stockholders to Reject TRC Capital's Mini-Tender Offer Centene Corporation has advised its stockholders to reject an unsolicited mini-tender offer from TRC Capital, which undervalues its shares. The SEC has also warned investors to evaluate such offers carefully, highlighting risks associated with selling shares below market value.
July 30, 2025 Centene Corp. Launches Innovative Mobile Health Clinic in Hawai'i Centene Corp. has launched an innovative mobile health clinic in partnership with 'Ohana Health Plan and HICHC to enhance school-based healthcare in Hawai'i. The initiative aims to provide crucial health services directly to students, particularly in underserved areas, starting with a phased rollout across multiple public schools.
July 25, 2025 Centene Corp. Reports Mixed Financial Results for Q2 2025 Centene Corp. reported mixed financial results for Q2 2025, with revenues up 22% to $48.7 billion but a net loss of $253 million due to rising medical costs. The company faces challenges from regulatory changes impacting Medicaid and Medicare but shows adaptability with growth in marketplace membership.
July 25, 2025 Centene Corporation Reports Mixed Second Quarter 2025 Results Centene Corporation's Q2 2025 results show a revenue increase to $48.7 billion, driven by Medicare and Marketplace growth. However, the company faces challenges with declining Medicaid membership and increased health benefits ratios, leading to a diluted loss per share.
July 22, 2025 Centene Corporation Prepares to Release Q2 2025 Financial Results Centene Corporation is set to release its Q2 2025 financial results on July 25, 2025, followed by a conference call at 8:00 a.m. ET. Investors can attend via phone or webcast, with replay options available for those unable to join live.
July 01, 2025 Centene Corporation Withdraws 2025 Guidance Amidst Market Concerns Centene Corporation has withdrawn its 2025 financial guidance following lower-than-expected marketplace growth and morbidity trends. The company anticipates significant adjustments to revenue projections and is reevaluating its 2026 Marketplace rates as it navigates these challenges.
May 02, 2025 Centene Corp. Expands Reach in Arizona's Long-Term Care Medicaid Program Centene Corporation's Arizona Complete Health has entered a settlement agreement to manage long-term care for 26,000 Arizonans starting October 2025. This three-year contract aims to improve healthcare services for the elderly and disabled, marking a significant milestone in Arizona's healthcare system.
April 25, 2025 Centene Corporation Reports Strong First Quarter 2025 Results Centene Corporation achieved robust financial results for Q1 2025, with revenues of $46.62 billion and a significant increase in at-risk membership. Strategic expansions in Medicaid and Marketplace services, along with a focus on community engagement, position the company for continued growth in the evolving healthcare sector.
April 10, 2025 Centene's SilverSummit Healthplan Awarded Nevada Medicaid Contract Centene's SilverSummit Healthplan has been awarded a five-year Medicaid contract to expand managed care services in Nevada, targeting rural and underserved areas. This initiative aims to improve healthcare access for over 100,000 members while continuing to offer comprehensive services.
March 27, 2025 Centene Corp's 'Ohana Health Plan Invests $300,000 to Enhance Maternal and Child Health in Hawaii 'Ohana Health Plan, a Centene Corp subsidiary, invests $300,000 in Hawaii’s maternal and child health through the Mana 'Ohana program. This initiative aims to improve health outcomes for families by providing comprehensive, culturally responsive care.
March 24, 2025 Centene Corp. and 'Ohana Health Plan Invest in Future Nurses with $25,000 Scholarship Fund 'Ohana Health Plan has committed $25,000 to the University of Hawaii Foundation to fund the Pre-Nursing Scholarship at UH West Oʻahu. This initiative aims to alleviate financial burdens for students, addressing Hawaii's pressing nursing shortage and fostering future healthcare leaders.
March 18, 2025 Centene Corporation Set to Announce Q1 2025 Financial Results Centene Corporation will release its Q1 2025 financial results on April 25, followed by a conference call at 8:30 a.m. ET. Investors can participate via phone or webcast, with a replay available for twelve months.
March 17, 2025 Centene's Meridian Health Plan Wins Illinois D-SNP Contract Centene's Meridian Health Plan has been awarded a D-SNP contract in Illinois, enabling better service for dually eligible Medicare and Medicaid members. This initiative aims to streamline healthcare and improve access for over 77,000 individuals, reflecting Centene's commitment to integrated care.
March 07, 2025 Centene Corporation Announces Presentation at Barclays Annual Global Healthcare Conference Centene Corporation is set to present at the Barclays 27th Annual Global Healthcare Conference on March 12, 2025. This event offers investors key insights into the company's strategic direction and commitment to improving healthcare access for underserved populations.
February 25, 2025 SWOT Analysis of Centene Corp. in 2025 This SWOT analysis of Centene Corp. in 2025 details the company's strengths as the largest Medicaid insurer, alongside its weaknesses and regulatory challenges. It also identifies growth opportunities in underserved markets while addressing threats from competition and legal issues.
February 24, 2025 Centene Corporation Expands Board with Appointment of Kenneth Y. Tanji Centene Corporation has appointed Kenneth Y. Tanji to its Board of Directors, expanding its leadership team. Tanji, a seasoned finance executive, brings over 30 years of experience, notably as CFO of Prudential Financial. His expertise will be instrumental as Centene continues to address complex healthcare challenges.
February 18, 2025 Centene Corp. 2024 Annual Report: A Year of Strategic Growth and Challenges Centene Corp. reports significant growth in 2024, becoming the largest Medicaid insurer and expanding its Marketplace offerings. Despite challenges from Medicaid eligibility changes and Medicare ratings, the company remains financially strong with a net income increase.
February 11, 2025 Centene Corp. Announces $550,000 Grant to Expand Healthcare Access in Hawaii Centene Corporation has announced a $550,000 grant to support the 'Gateway to Health' initiative in Hawaii, aimed at improving healthcare access for students in underserved areas. The funding will enable the launch of a mobile health clinic, providing essential medical, dental, and mental health services directly to students in rural communities.
October 25, 2024 Centene Corp. Reports Strong Q3 2024 Results Centene Corporation reported strong Q3 2024 results, with a 10% revenue increase and membership growth of 670,000. The company is strategically expanding its Medicaid and Medicare offerings amidst regulatory challenges.
July 26, 2024 Centene Corp. Reports Strong Q2 2024 Results Amidst Dynamic Healthcare Landscape Centene Corp reported robust Q2 2024 results, with revenues rising to $39.83 billion thanks to significant Marketplace membership growth. Despite challenges in Medicaid, the company's strategic expansions and divestitures position it well for future success in the evolving healthcare landscape.
April 26, 2024 Centene Corp. Reports Q1 2024 Financial Results: A Mixed Bag Amidst Regulatory Changes Centene Corp. released its Q1 2024 financial results, showing a 4% revenue increase but a slight decline in Medicaid membership. Despite challenges, the company is expanding and remains committed to improving healthcare access for underserved populations.

Centene Corporation Announces Board of Directors Changes

Last updated: July 28, 2026 •
Taurigo

In a noteworthy development that reflects both continuity and change within its leadership, Centene Corporation (NYSE: CNC) has announced the retirement of Kenneth A. Burdick from its Board of Directors and the appointment of Paul J. Diaz, effective July 28, 2026. This transition marks a significant moment for the company, which is widely recognized as a leading healthcare enterprise.

1. Retirement of Kenneth A. Burdick

Kenneth A. Burdick, who joined Centene's Board in January 2022, has decided to step down to focus on personal priorities and explore new opportunities. Burdick’s contributions to the Board have been significant, leveraging his extensive experience in leadership roles within the healthcare sector. Prior to his tenure on the Board, he served as Executive Vice President of Products and Markets at Centene, and before that, he was the CEO of WellCare Health Plans.

Reflecting on his time at Centene, Burdick stated, "It has been a privilege to serve Centene and support its mission of transforming the health of the communities it serves, one person at a time. I have great confidence in the Company's leadership, strategy, and future, and I leave knowing it is well positioned for its next chapter of growth and impact."

2. Welcoming Paul J. Diaz to the Board

In contrast, Paul J. Diaz brings a wealth of experience to the Board, having served in executive roles at various healthcare organizations. Currently, he is a Managing Partner at Cressey & Company, a private investment firm that specializes in the healthcare sector. Previously, he held the positions of President and CEO at Myriad Genetics, Inc., and Kindred Healthcare, a Fortune 500 company. Diaz's extensive background is further complemented by his public company board experience, having served on the boards of prominent healthcare organizations such as DaVita and PharMerica.

Expressing his enthusiasm for joining Centene, Diaz remarked, "I am honored to join Centene's Board of Directors and support a company with such a strong mission and commitment to improving the health of the communities it serves. I look forward to drawing on my experience across the healthcare industry to help advance innovation, strengthen access to high-quality care and support Centene's continued impact for its members and stakeholders."

3. Board Chair's Perspective

Frederick H. Eppinger, Chair of Centene's Board of Directors, expressed gratitude towards Burdick for his service, noting, "Ken has been a valued member of our Board. His deep industry expertise, strategic perspective, and commitment to improving healthcare have made a meaningful impact on Centene." Eppinger also welcomed Diaz, emphasizing that his leadership experience and governance expertise will be instrumental as Centene continues to implement its strategic initiatives and enhance its service offerings.

4. About Centene Corporation

Centene Corporation is a Fortune 500 company dedicated to improving the health of individuals, particularly those who are under-insured. The company operates with a local approach, employing local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs. Centene’s reach extends to over 1 in 15 individuals across the United States, including members of Medicaid, Medicare, and those utilizing the Health Insurance Marketplace.

In summary, the changes in Centene's Board of Directors signal a proactive approach to governance and leadership in the ever-evolving healthcare landscape. With Burdick’s departure and Diaz’s arrival, Centene is poised to continue its mission of transforming healthcare while navigating the complexities of the industry.

Original press release
You may also be interested in:
Products
Resources
Legal
Company
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.